BloodPressureHeartMeds.Net

FSU assistant professor unlocks mysteries of KSHV infection

April 06, 2017

Now, Zhu's latest grant will help him to clarify the KSHV ORF45 protein's role not only within cellular signaling pathways but also in immune evasion -- the process by which an invading organism avoids or suppresses the host's immune responses to it.

Unlocking what once were the mysteries of the KSHV infection and replication are crucial to developing effective therapies because, despite the success of highly active antiretroviral therapy against HIV, KS remains a serious disease and the most common cancer among HIV/AIDS patients. KSHV also is associated with other human cancers such as primary effusion lymphoma and multicentric Castleman's disease.

In Africa, KS accounts for nearly half of the reported cancers and is the leading cause of cancer death in some areas. Current treatments for KSHV-associated diseases are not optimal because they don't attack the viral agent specifically.

"Dr. Zhu's work on KSHV ORF45 aims to give us a drug target that is specific to the virus," Chase said. "The newly funded studies should take??? him even closer to that goal."

Since 2008, nine papers coauthored by Zhu's research team have been featured in leading peer-reviewed publications, including the Journal of Virology, PLoS Pathogens, Journal of Biological Chemistry and Journal of Immunology.

Source: Florida State University